Immix Biopharma Inc
IMMX
Get informed when a big investor buys or sells
+ FollowMarket Cap$528.79M
Close$
$2.82
74.2% downside
Current Fair Value
74.2% downsideOvervalued by 74.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $528.79 Million |
|---|---|
| Enterprise Value | $304.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.89 |
| Beta | 0.11 |
| Outstanding Shares | 63,771,377 |
Return
| Return on Equity | -17.44% |
|---|---|
| Return on Assets | -16.69% |
| Return on Invested Capital | -18.11% |
Valuation & Multiples
| P/E Ratio | -11.05 |
|---|---|
| PEG | -14.82 |
| Price to Sales | - |
| Price to Book Ratio | 3.64 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.31 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 14, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.5154▲ 200.97% |
|---|---|
| Total Calls | 26,000▼ 26.14% |
| Total Puts | 91,400▲ 72.45% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 70.72%▲ 7.04% |
|---|---|
| Total Invested | $246.62M▲ 93.43% |
| Investors Holding | 79▲ 10.00% |
ESG Score
No data